Thermobalancing therapy with Dr Allen’s Device is a new instrument for men to reverse benign prostatic hyperplasia (BPH) and help to recover from chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Ms. Ariana Adjani, co-founder of Fine Treatment, UK, and inventor of medical thermobalancing technology, presents this safe treatment at many scientific and business meetings.
The Prevalence of BPH and CP/CPPS is High
According to the National Institutes of Health, approximately 14 million men in the United States have urinary symptoms associated with enlarged prostate or BPH. 50% of men aged 51 to 60 years have BPH, and 6.3% of adults have symptoms of CP/CPPS.
Since non-cancerous chronic prostate diseases are very common, their treatment must be, firstly, safe, and secondly, cost-effective. The medical article, Innovative Thermobalancing Therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively, shows the benefits of Thermobalancing therapy over other treatment options.
Market Forecast for Drugs and Instruments for BPH and CP/CPPS
The increase in the male geriatric population is leading to an increase in the incidence of BPH and, as a result, an increase in demand for BPH and drugs and devices for the treatment of CP/CPPS.
The global prostatitis drugs market was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025. According to the world’s largest market research house, the market for devices used to treat symptomatic BPH and CP/CPPS is expected to experience moderate growth to approximately $586 million in next 4 years.
What Are the Most Common Treatment Options for BPH and CP/CPPS?
Six treatment options are considered as common: prescription combination therapy (“ComboRx”), a 5α-reductase inhibitor (eg, dutasteride or finasteride), and a selective α-blocker (eg, tamsulosin or doxazosin). Many different surgical procedures are discussed in various medical articles.
The drug option is the least expensive but is not cost-effective because it requires long-term use to achieve some improvement in urinary symptoms in men with BPH and some pain relief in men with CP/CPPS symptoms. At the same time, surgical interventions in men with BPH have the highest procedural cost. In addition, both of these medical interventions are unsafe.
Medical Treatments for BPH and CP/CPPS Can Be Harmful
Alpha-blockers are the most commonly prescribed treatment; relaxing the smooth muscles of the neck of the bladder and in the prostate gland, they facilitate urination. All of them have similar side effects: weakness, headaches, loss of seminal emission, etc.
5-alpha-reductase inhibitors have a hormonal effect converting testosterone into dihydrotestosterone. They all may develop serious irreversible health problems, like impotence, diabetes, and depression.
According to various observations, complications and side effects after prostate surgeries for BPH include: acute urinary retention, erectile dysfunction, urinary incontinence, stricture, contracture or stenosis, and urinary tract infection.
Thermobalancing therapy is Cost-Effective MedTech for BPH and CP/CPPS
Dr Allen’s device consists of thermoelement, which is made from the special mixture of waxes, and the belt that applies this thermoelement to the body. The cost of Dr Allen’s Device is under $200, that compares highly favourably to standard treatment options.
Annual medical costs for men with BPH are over $5,000. The expected annual total cost per patient with CP/CPPS is $4397. Thus, medical thermobalancing technology is the most cost-effective treatment option for BPH and CP/CPPS.
Dr Allen’s Device is a class 1 medical device, which does not require the involvement of a notified body in any country. So, everyone can use this device at home without worrying, as this treatment option causes no side effects. The delivery of Dr Allen’s Device is guaranteed by Royal mail tracking services.